And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is dominated by festivities scheduled for our shortest person, who passed another milestone on the calendar. Otherwise, we plan to indulge by reading and napping. And what about you? This remains a lovely time of year to enjoy the great outdoors — perhaps a pumpkin is in your future. It is never too soon to plan an end-of-year getaway. Or you could look ahead toward your health insurance choices for next year, or what is left of them. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

Amazon (AMZN) has received approval for wholesale pharmacy licenses in at least 12 states, according to The St. Louis Post-Dispatch. These include Nevada, Arizona, North Dakota, Louisiana, Alabama, New Jersey, Michigan, Connecticut, Idaho, New Hampshire, Oregon, and Tennessee, underscoring mounting speculation the company is poised to enter the pharmacy business. Not surprisingly, the news sent shares in drugstore chains down.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy